Compound Evidence File
#EC-2026-0133
Retatrutide(GLP-1, GIP, and GCGR agonist)
Filed under Peptides. The bureau holds 2,101 laboratory returns for this compound from 154 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
154 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| HomopeptideCASE #VI-2026-0760 | A | 6 | 10.0 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| Bulk Peptide WholesaleCASE #VI-2026-0319 | A | 2 | 10.0 | 10.0 | 10.0 | 19 May 2026 | 19 May 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 5 | 9.9 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Regenerative ResearchCASE #VI-2026-0349 | X | 1 | 9.7 | 9.7 | 9.7 | 20 Jun 2025 | 20 Jun 2025 |
| Paradigm PeptideCASE #VI-2026-0759 | A | 6 | 9.6 | 7.6 | 10.0 | 24 Jul 2025 | 4 Sep 2025 |
| NUPEPS PeptidesCASE #VI-2026-0896 | A | 2 | 9.5 | 9.3 | 9.8 | 16 Dec 2025 | 16 Dec 2025 |
| Coffee and PeppersCASE #VI-2026-0274 | X | 1 | 9.5 | 9.5 | 9.5 | 25 May 2026 | 25 May 2026 |
| Yabang PeptideCASE #VI-2026-0148 | X | 1 | 9.4 | 9.4 | 9.4 | 25 May 2026 | 25 May 2026 |
| Peptide PartnersCASE #VI-2026-0295 | A | 16 | 8.8 | 6.7 | 10.0 | 17 Jul 2025 | 24 May 2026 |
| Orbitrex PeptidesCASE #VI-2026-0812 | A | 9 | 8.8 | 6.5 | 10.0 | 7 Oct 2025 | 24 May 2026 |
| SubQ SocietyCASE #VI-2026-0716 | A | 2 | 8.8 | 8.1 | 9.5 | 25 May 2026 | 25 May 2026 |
| Pure RawzCASE #VI-2026-0767 | A | 4 | 8.6 | 8.1 | 9.1 | 6 May 2025 | 21 May 2025 |
| Risynth BioCASE #VI-2026-0672 | A | 4 | 8.6 | 6.0 | 10.0 | 1 Sep 2025 | 4 Sep 2025 |
| Marvel PeptideCASE #VI-2026-0507 | X | 1 | 8.6 | 8.6 | 8.6 | 25 May 2026 | 25 May 2026 |
| Peptide HavenCASE #VI-2026-0898 | A | 2 | 8.5 | 8.4 | 8.6 | 2 Dec 2025 | 2 Dec 2025 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 5 | 8.4 | 7.9 | 9.5 | 21 May 2026 | 21 May 2026 |
| NuLife PeptidesCASE #VI-2026-0980 | A | 2 | 8.4 | 7.8 | 9.0 | 24 May 2026 | 24 May 2026 |
| Bfflist AMOCASE #VI-2026-0678 | B | 45 | 8.4 | 5.7 | 10.0 | 30 Jun 2025 | 21 May 2026 |
| Aavant ResearchCASE #VI-2026-0831 | A | 7 | 8.3 | 6.2 | 9.5 | 11 Aug 2025 | 24 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 7 | 8.3 | 7.3 | 10.0 | 24 May 2026 | 24 May 2026 |
| Pura PeptidesCASE #VI-2026-0307 | X | 1 | 8.3 | 8.3 | 8.3 | 24 Jul 2025 | 24 Jul 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 8 | 8.2 | 7.1 | 10.0 | 21 May 2026 | 21 May 2026 |
| Lux Synth AminosCASE #VI-2026-0700 | A | 2 | 8.2 | 7.2 | 9.1 | 22 May 2026 | 22 May 2026 |
| Yiwu Aozuo Trading CoCASE #VI-2026-0798 | C | 26 | 8.2 | 4.9 | 10.0 | 4 Aug 2025 | 23 May 2026 |
| Huaian Hanyou PeptideCASE #VI-2026-0297 | A | 7 | 8.1 | 6.5 | 10.0 | 14 Nov 2025 | 24 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 6 | 8.1 | 6.5 | 10.0 | 25 May 2026 | 25 May 2026 |
| Zhang TYCASE #VI-2026-0070 | A | 3 | 8.1 | 7.3 | 9.3 | 30 Jun 2025 | 7 Jan 2026 |
| BfflinkCASE #VI-2026-0212 | B | 13 | 8.1 | 5.8 | 10.0 | 16 Dec 2025 | 24 May 2026 |
| Xingruida XDRCASE #VI-2026-0898 | D | 22 | 8.1 | 3.6 | 10.0 | 20 Jun 2025 | 23 May 2026 |
| Lisa BiopeptideCASE #VI-2026-0131 | A | 11 | 8.0 | 6.0 | 9.4 | 13 Dec 2025 | 24 May 2026 |
| Mai PeptideCASE #VI-2026-0769 | E | 25 | 8.0 | 2.2 | 10.0 | 4 Nov 2025 | 22 May 2026 |
| PepKitsCASE #VI-2026-0320 | X | 1 | 8.0 | 8.0 | 8.0 | 25 May 2026 | 25 May 2026 |
| LipeptidesCASE #VI-2026-0863 | A | 7 | 7.9 | 6.6 | 10.0 | 6 Dec 2025 | 20 May 2026 |
| Atomik LabzCASE #VI-2026-0327 | A | 6 | 7.9 | 6.8 | 9.0 | 6 May 2025 | 24 May 2026 |
| Skye PeptidesCASE #VI-2026-0451 | B | 10 | 7.9 | 6.0 | 9.5 | 17 Dec 2024 | 14 Aug 2025 |
| Shanghai JinBei Chemical TechnologyCASE #VI-2026-0107 | B | 9 | 7.9 | 5.2 | 10.0 | 13 Dec 2025 | 24 May 2026 |
| HkRoidsCASE #VI-2026-0784 | B | 8 | 7.9 | 5.8 | 9.9 | 4 Aug 2025 | 24 May 2026 |
| LiliPeptideCASE #VI-2026-0695 | E | 101 | 7.9 | 0.0 | 10.0 | 4 Aug 2025 | 24 May 2026 |
| Zenith Jove Peptide ZJCASE #VI-2026-0570 | A | 9 | 7.8 | 6.8 | 9.4 | 16 Dec 2025 | 24 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 2 | 7.8 | 6.6 | 9.0 | 24 May 2026 | 24 May 2026 |
| Shenzhen Loga Tech LG LOGACASE #VI-2026-0920 | B | 9 | 7.8 | 5.5 | 10.0 | 21 Aug 2025 | 20 May 2026 |
| Tianjin Ruiwang New Material Technology CoCASE #VI-2026-0192 | E | 50 | 7.8 | 0.0 | 10.0 | 4 Sep 2025 | 24 May 2026 |
| Wuhan Newtop BiotechCASE #VI-2026-0676 | X | 1 | 7.8 | 7.8 | 7.8 | 25 May 2026 | 25 May 2026 |
| Zhuoyue BiotechnologyCASE #VI-2026-0632 | X | 1 | 7.8 | 7.8 | 7.8 | 25 May 2026 | 25 May 2026 |
| Shandong Shengyuan Peptide TechnologyCASE #VI-2026-0634 | A | 9 | 7.7 | 6.5 | 9.5 | 17 Nov 2025 | 21 May 2026 |
| NextechLabsCASE #VI-2026-0285 | A | 7 | 7.7 | 6.5 | 9.4 | 14 Jan 2025 | 9 Oct 2025 |
| YB PeptideCASE #VI-2026-0813 | A | 6 | 7.7 | 6.0 | 8.5 | 21 Aug 2025 | 19 May 2026 |
| PurePeptidesCASE #VI-2026-0234 | A | 5 | 7.7 | 6.8 | 9.4 | 27 Feb 2025 | 19 Jan 2026 |
| OmegAminoCASE #VI-2026-0014 | A | 4 | 7.7 | 6.3 | 10.0 | 20 Jun 2025 | 12 Aug 2025 |
| PeptiSlimCASE #VI-2026-0557 | C | 22 | 7.7 | 4.4 | 10.0 | 1 Sep 2025 | 25 May 2026 |
| Rayshine Peptide BiochemicalsCASE #VI-2026-0545 | C | 6 | 7.7 | 4.4 | 10.0 | 12 Aug 2025 | 19 Jan 2026 |
| Peptide CraftersCASE #VI-2026-0994 | A | 6 | 7.6 | 6.6 | 9.5 | 17 Dec 2024 | 16 Dec 2025 |
| CellupepCASE #VI-2026-0888 | B | 7 | 7.6 | 5.3 | 10.0 | 17 Nov 2025 | 21 May 2026 |
| Xingtai Jiachuang TechnologyCASE #VI-2026-0712 | C | 8 | 7.6 | 4.5 | 9.5 | 4 Jul 2025 | 26 Jan 2026 |
| Reta-PeptideCASE #VI-2026-0756 | E | 53 | 7.6 | 0.0 | 10.0 | 20 Jun 2025 | 24 May 2026 |
| TCICASE #VI-2026-0650 | X | 1 | 7.6 | 7.6 | 7.6 | 10 Jun 2025 | 10 Jun 2025 |
| PepLab SolutionsCASE #VI-2026-0431 | X | 1 | 7.6 | 7.6 | 7.6 | 25 May 2026 | 25 May 2026 |
| Shanghai Leader Peptide BiotechnologyCASE #VI-2026-0558 | B | 8 | 7.5 | 5.8 | 10.0 | 29 Dec 2025 | 23 May 2026 |
| Paramount PeptidesCASE #VI-2026-0550 | C | 12 | 7.5 | 4.3 | 9.3 | 14 Jan 2025 | 6 Dec 2025 |
| Dankang BioHealthCASE #VI-2026-0775 | C | 12 | 7.5 | 4.2 | 10.0 | 1 Jan 2026 | 24 May 2026 |
| SRY LabsCASE #VI-2026-0657 | E | 28 | 7.5 | 1.5 | 10.0 | 20 Apr 2025 | 24 May 2026 |
| HK Fat CatCASE #VI-2026-0376 | X | 1 | 7.5 | 7.5 | 7.5 | 25 May 2026 | 25 May 2026 |
| Hebei Rimao TechnologyCASE #VI-2026-0529 | C | 17 | 7.4 | 4.1 | 9.8 | 11 Aug 2025 | 24 May 2026 |
| Kits4lessCASE #VI-2026-0744 | C | 7 | 7.4 | 4.7 | 10.0 | 16 Jul 2025 | 24 May 2026 |
| Qing Li PeptideCASE #VI-2026-0469 | E | 96 | 7.4 | 2.8 | 10.0 | 9 Jun 2025 | 24 May 2026 |
| Loti LabsCASE #VI-2026-0171 | A | 5 | 7.3 | 6.0 | 8.0 | 16 Mar 2025 | 6 May 2025 |
| Limitless Life NootropicsCASE #VI-2026-0980 | B | 4 | 7.3 | 5.8 | 10.0 | 13 Feb 2025 | 19 Feb 2025 |
| UtherCASE #VI-2026-0902 | C | 13 | 7.3 | 4.7 | 10.0 | 3 Jul 2025 | 24 May 2026 |
| InjectifyCASE #VI-2026-0387 | C | 4 | 7.3 | 4.1 | 8.7 | 16 May 2025 | 23 Jul 2025 |
| Polaris PeptidesCASE #VI-2026-0839 | D | 26 | 7.3 | 3.9 | 9.0 | 17 Dec 2024 | 7 Jan 2026 |
| NexaphCASE #VI-2026-0944 | E | 82 | 7.3 | 0.0 | 10.0 | 11 Jun 2025 | 25 May 2026 |
| Nuscience PeptidesCASE #VI-2026-0554 | A | 8 | 7.2 | 6.1 | 10.0 | 22 Apr 2025 | 20 May 2026 |
| Allen Biotechnology Co ABCCASE #VI-2026-0709 | B | 12 | 7.2 | 5.3 | 9.0 | 4 Aug 2025 | 23 May 2026 |
| Henan Sahe PeptideCASE #VI-2026-0894 | B | 11 | 7.2 | 5.3 | 10.0 | 30 Sep 2025 | 23 May 2026 |
| Hunan Ruiwang Technology CenterCASE #VI-2026-0027 | B | 10 | 7.2 | 5.5 | 8.0 | 4 Sep 2025 | 24 May 2026 |
| Yongkang Nuoao Trading CoCASE #VI-2026-0646 | B | 8 | 7.2 | 5.8 | 9.0 | 25 Jul 2025 | 24 May 2026 |
| Peptronix Bio PTBCASE #VI-2026-0979 | B | 8 | 7.2 | 5.7 | 8.0 | 5 Aug 2025 | 22 May 2026 |
| Zztai PeptideCASE #VI-2026-0192 | C | 11 | 7.2 | 5.0 | 9.6 | 9 Jun 2025 | 22 May 2026 |
| HK PeptidesCASE #VI-2026-0140 | E | 110 | 7.2 | 0.0 | 10.0 | 11 Jun 2025 | 24 May 2026 |
| TSC Top Supplements ChinaCASE #VI-2026-0523 | E | 43 | 7.2 | 2.0 | 10.0 | 3 Jun 2025 | 23 May 2026 |
| EHZ PeptidesCASE #VI-2026-0296 | C | 25 | 7.1 | 4.6 | 10.0 | 20 Jun 2025 | 24 May 2026 |
| Hangzhou Mandy BiotechnologyCASE #VI-2026-0695 | C | 7 | 7.1 | 4.4 | 9.8 | 17 Nov 2025 | 24 May 2026 |
| Liberty PeptidesCASE #VI-2026-0416 | C | 6 | 7.1 | 4.3 | 10.0 | 31 Mar 2025 | 7 Jan 2026 |
| Kerisite Shenzhen InternationalCASE #VI-2026-0315 | D | 14 | 7.1 | 3.4 | 10.0 | 25 Jun 2025 | 24 May 2026 |
| Zhejiang Yichenkang BiotechnologyCASE #VI-2026-0269 | D | 11 | 7.1 | 3.3 | 10.0 | 11 Jun 2025 | 11 Dec 2025 |
| ZLZ PeptideCASE #VI-2026-0524 | E | 78 | 7.1 | 0.0 | 10.0 | 20 Jun 2025 | 24 May 2026 |
| OupeptideCASE #VI-2026-0435 | E | 53 | 7.1 | 0.0 | 10.0 | 9 Jun 2025 | 24 May 2026 |
| Shanxi Qianyecao Biotech QYCCASE #VI-2026-0189 | E | 41 | 7.1 | 0.0 | 10.0 | 24 Jul 2025 | 24 May 2026 |
| Lejian Biotech PeptideCASE #VI-2026-0746 | X | 1 | 7.1 | 7.1 | 7.1 | 25 May 2026 | 25 May 2026 |
| Peptide WorldwideCASE #VI-2026-0217 | X | 1 | 7.1 | 7.1 | 7.1 | 6 May 2025 | 6 May 2025 |
| Verified PeptidesCASE #VI-2026-0407 | B | 4 | 7.0 | 5.9 | 9.7 | 13 Feb 2025 | 19 Feb 2025 |
| BeiBangAnCASE #VI-2026-0899 | C | 23 | 7.0 | 4.4 | 9.8 | 29 Oct 2025 | 24 May 2026 |
| Huayi BiotechnologyCASE #VI-2026-0243 | C | 11 | 7.0 | 4.5 | 9.3 | 1 Sep 2025 | 22 May 2026 |
| Peptide-SCASE #VI-2026-0111 | E | 40 | 7.0 | 0.0 | 10.0 | 11 Jun 2025 | 22 May 2026 |
| Shandong Aishi BiotechnologyCASE #VI-2026-0308 | E | 16 | 7.0 | 0.8 | 10.0 | 24 Oct 2025 | 24 May 2026 |
| Shanghai BaojuCASE #VI-2026-0233 | E | 11 | 7.0 | 2.0 | 10.0 | 3 Oct 2025 | 24 May 2026 |
| Xingtai Pukelai Technology CoCASE #VI-2026-0850 | C | 6 | 6.9 | 4.1 | 9.9 | 11 Aug 2025 | 29 Dec 2025 |
| Quenna PMQCASE #VI-2026-0415 | D | 7 | 6.9 | 3.6 | 9.7 | 5 Oct 2025 | 1 Jan 2026 |
| ZZQ PeptidesCASE #VI-2026-0550 | E | 11 | 6.9 | 0.0 | 9.5 | 24 Jul 2025 | 21 May 2026 |
| Oasis PeptidesCASE #VI-2026-0404 | B | 7 | 6.8 | 5.7 | 7.9 | 14 Jan 2025 | 24 Jul 2025 |
| Royal PeptidesCASE #VI-2026-0264 | C | 13 | 6.8 | 4.6 | 8.8 | 16 Mar 2025 | 24 May 2026 |
| Heman Peptide HMCASE #VI-2026-0089 | E | 19 | 6.8 | 2.9 | 9.8 | 23 Oct 2025 | 25 May 2026 |
| Guangzhou Yuao TradingCASE #VI-2026-0787 | X | 1 | 6.8 | 6.8 | 6.8 | 25 May 2026 | 25 May 2026 |
| Haikou Mingheng TechnologyCASE #VI-2026-0250 | B | 7 | 6.7 | 5.8 | 8.0 | 3 Oct 2025 | 24 May 2026 |
| LN PeptidesCASE #VI-2026-0781 | B | 7 | 6.7 | 5.0 | 8.0 | 17 Nov 2025 | 21 May 2026 |
| Champion PeptideCASE #VI-2026-0909 | B | 6 | 6.7 | 5.6 | 8.1 | 11 Dec 2025 | 7 Jan 2026 |
| Chimera PeptidesCASE #VI-2026-0260 | C | 7 | 6.7 | 4.7 | 8.0 | 13 Oct 2025 | 22 May 2026 |
| Amino AmigosCASE #VI-2026-0061 | C | 2 | 6.7 | 4.0 | 9.4 | 14 Jan 2025 | 23 Jan 2025 |
| Mix PeptidesCASE #VI-2026-0699 | D | 9 | 6.7 | 3.3 | 9.1 | 23 Oct 2025 | 24 May 2026 |
| M-PeptidesCASE #VI-2026-0442 | C | 7 | 6.6 | 4.8 | 9.5 | 21 Oct 2025 | 21 May 2026 |
| Platinum CryoCASE #VI-2026-0406 | C | 6 | 6.6 | 5.0 | 8.0 | 22 Apr 2025 | 7 May 2025 |
| YimeiCASE #VI-2026-0081 | E | 40 | 6.6 | 0.0 | 9.8 | 20 Jun 2025 | 25 May 2026 |
| Xingtai Lesda TechnologyCASE #VI-2026-0381 | E | 6 | 6.6 | 0.0 | 10.0 | 1 Sep 2025 | 23 Oct 2025 |
| Planet PeptideCASE #VI-2026-0092 | C | 14 | 6.5 | 4.5 | 8.5 | 17 Dec 2024 | 20 May 2026 |
| Shanghai ERP peptide BiotechnologyCASE #VI-2026-0500 | C | 12 | 6.5 | 4.8 | 8.0 | 11 Dec 2025 | 25 May 2026 |
| Biolongevity LabsCASE #VI-2026-0442 | C | 11 | 6.5 | 4.4 | 8.0 | 31 Mar 2025 | 23 Jul 2025 |
| Zen PeptidesCASE #VI-2026-0940 | C | 9 | 6.5 | 4.2 | 7.8 | 23 Oct 2025 | 24 May 2026 |
| Qingdao Saber Technology Pharma QSTCASE #VI-2026-0467 | C | 7 | 6.5 | 4.7 | 10.0 | 3 Jun 2025 | 29 Dec 2025 |
| Top PeptideCASE #VI-2026-0721 | C | 6 | 6.5 | 4.2 | 10.0 | 13 Oct 2025 | 22 Jan 2026 |
| HXNetCASE #VI-2026-0061 | E | 33 | 6.5 | 0.0 | 9.7 | 11 Aug 2025 | 24 May 2026 |
| Hebei Chengtong TechnologyCASE #VI-2026-0520 | X | 1 | 6.5 | 6.5 | 6.5 | 25 May 2026 | 25 May 2026 |
| Eternal PeptidesCASE #VI-2026-0842 | B | 4 | 6.4 | 5.8 | 6.9 | 7 May 2025 | 21 May 2025 |
| ZhuoYan labCASE #VI-2026-0902 | C | 12 | 6.4 | 4.3 | 8.0 | 4 Aug 2025 | 19 May 2026 |
| Welon Peptide SolutionsCASE #VI-2026-0478 | D | 5 | 6.4 | 3.3 | 7.8 | 23 Nov 2025 | 22 May 2026 |
| LSPLCASE #VI-2026-0523 | E | 20 | 6.4 | 1.6 | 10.0 | 6 Nov 2025 | 21 May 2026 |
| Bulk Peptide SupplyCASE #VI-2026-0446 | E | 5 | 6.4 | 0.0 | 9.5 | 11 Aug 2025 | 18 Sep 2025 |
| Pharma Grade PeptidesCASE #VI-2026-0208 | B | 2 | 6.3 | 6.3 | 6.3 | 7 May 2025 | 7 May 2025 |
| UWA Elite PeptidesCASE #VI-2026-0130 | E | 11 | 6.3 | 2.7 | 8.8 | 16 Jul 2025 | 21 May 2026 |
| Golden EagleCASE #VI-2026-0680 | C | 8 | 6.2 | 4.9 | 9.7 | 3 Aug 2025 | 15 Jan 2026 |
| Amino LairCASE #VI-2026-0413 | D | 6 | 6.2 | 4.0 | 8.0 | 21 Aug 2025 | 10 Dec 2025 |
| Alpha-GenCASE #VI-2026-0905 | D | 5 | 6.2 | 4.0 | 7.8 | 24 Apr 2025 | 21 May 2025 |
| Haikou Mingheng BiotechnologyCASE #VI-2026-0126 | D | 5 | 6.2 | 3.8 | 8.0 | 18 Sep 2025 | 23 May 2026 |
| Changan District Sheng Peptide TradingCASE #VI-2026-0341 | E | 7 | 6.2 | 0.0 | 9.7 | 10 Sep 2025 | 22 May 2026 |
| Peptide SciencesCASE #VI-2026-0867 | E | 37 | 6.1 | 2.0 | 10.0 | 17 Dec 2024 | 24 May 2026 |
| Simple PeptideCASE #VI-2026-0782 | C | 4 | 6.0 | 4.7 | 7.7 | 25 Apr 2025 | 6 May 2025 |
| Xian Yihang TechnologyCASE #VI-2026-0656 | D | 16 | 5.9 | 3.5 | 8.0 | 27 Jun 2025 | 24 May 2026 |
| Coastal PeptidesCASE #VI-2026-0958 | D | 5 | 5.9 | 3.8 | 7.9 | 27 Feb 2025 | 20 Mar 2025 |
| PRIVATECASE #VI-2026-0635 | X | 1 | 5.9 | 5.9 | 5.9 | 24 May 2026 | 24 May 2026 |
| Accelerate LabsCASE #VI-2026-0686 | C | 3 | 5.8 | 4.1 | 6.9 | 16 May 2025 | 23 Jul 2025 |
| Modern AminosCASE #VI-2026-0635 | E | 4 | 5.8 | 0.0 | 7.9 | 20 Jun 2025 | 5 Oct 2025 |
| Elite Research USACASE #VI-2026-0267 | C | 7 | 5.6 | 4.8 | 6.9 | 30 Apr 2025 | 7 Jan 2026 |
| Amino AsylumCASE #VI-2026-0828 | C | 2 | 5.6 | 4.8 | 6.5 | 14 Feb 2025 | 19 Feb 2025 |
| Suaway Lab ResearchCASE #VI-2026-0488 | C | 5 | 5.5 | 4.3 | 6.3 | 31 Mar 2025 | 16 May 2025 |
| Hangzhou Youngpeptide Biotechnology HYBCASE #VI-2026-0347 | E | 7 | 5.5 | 0.0 | 8.0 | 5 Aug 2025 | 19 May 2026 |
| TydesCASE #VI-2026-0493 | D | 9 | 5.2 | 3.8 | 7.2 | 17 Dec 2024 | 30 Apr 2025 |
| Wolverine PeptidesCASE #VI-2026-0262 | X | 1 | 5.0 | 5.0 | 5.0 | 3 Jul 2025 | 3 Jul 2025 |
| Nanjing Xiyuxun Technology XYXCASE #VI-2026-0433 | D | 2 | 4.9 | 4.1 | 5.7 | 20 May 2025 | 23 Oct 2025 |
| Shanghai OuDaXin New Material Technology CenterCASE #VI-2026-0498 | E | 12 | 4.9 | 0.0 | 10.0 | 11 Aug 2025 | 19 May 2026 |
| Shaanxi Dideu MedichemCASE #VI-2026-0499 | E | 6 | 4.9 | 0.0 | 7.4 | 3 Jun 2025 | 24 May 2026 |
| Amplified AminoCASE #VI-2026-0748 | E | 4 | 4.2 | 2.2 | 7.0 | 13 Feb 2025 | 19 Feb 2025 |
| WllyBIOCASE #VI-2026-0470 | X | 1 | 3.6 | 3.6 | 3.6 | 3 Jul 2025 | 3 Jul 2025 |
| Forever Young PharmacyCASE #VI-2026-0654 | E | 8 | 2.9 | 1.5 | 7.1 | 17 Dec 2024 | 31 Mar 2025 |
| Alimo PeptideCASE #VI-2026-0524 | E | 3 | 2.9 | 0.0 | 4.4 | 11 Jun 2025 | 13 Oct 2025 |
| Peptide GurusCASE #VI-2026-0854 | E | 7 | 0.8 | 0.0 | 5.4 | 16 Mar 2025 | 3 Jul 2025 |
Open any subject to view the batch-level evidence for Retatrutide(GLP-1, GIP, and GCGR agonist) alone.